Pfizer Inc. (BIT:1PFE)

Market Cap	118.06B
Revenue (ttm)	57.67B
Net Income (ttm)	7.28B
Shares Out	n/a
EPS (ttm)	1.28
PE Ratio	16.22
Forward PE	7.80
Dividend	1.57 (7.87%)
Ex-Dividend Date	May 8, 2025

Volume	31,096
Average Volume	9,332
Open	20.50
Previous Close	19.94
Day's Range	19.32 - 20.65
52-Week Range	18.73 - 29.30
Beta	n/a
RSI	46.44
Earnings Date	Apr 29, 2025

About Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral pr...

• Industry: Pharmaceutical Preparations
• Founded: 1849
• Employees: 81,000
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1PFE

Financial Performance

In 2024, Pfizer's revenue was $63.63 billion, an increase of 6.84% compared to the previous year's $59.55 billion. Earnings were $8.03 billion, an increase of 279.00%.

Financial numbers in USD